ALL-associated JAK1 mutations confer hypersensitivity to the antiproliferative effect of type I interferon
Tekla Hornakova(Ludwig Cancer Research), Laurent Knoops(Cliniques Universitaires Saint-Luc)
Cited by 26
Related Papers
Oncogenic JAK1 and JAK2-activating mutations resistant to ATP-competitive inhibitors
|Haematologica|2011|77
Acute Lymphoblastic Leukemia-associated JAK1 Mutants Activate the Janus Kinase/STAT Pathway via Interleukin-9 Receptor α Homodimers
|Journal of Biological Chemistry|2009|65